U.S. Renewable Energy Stock News

NasdaqCM:AKBA
NasdaqCM:AKBABiotechs

Akebia Therapeutics (AKBA) Is Down 14.5% After Swing To Q1 Loss And Share Increase Plan

Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss of US$9.05 million replacing prior net income of US$6.11 million. A recent proposal to increase authorized capital stock to 525,000,000 shares, including 500,000,000 common shares, adds a potential dilution and financing angle to Akebia’s weaker quarterly performance. Next, we’ll examine how the shift to a quarterly loss alongside...
NYSE:MET
NYSE:METInsurance

Is MetLife (MET) Offering Value After Recent 10.7% Share Price Gain?

If you are wondering whether MetLife at around US$78.82 offers fair value or a margin of safety, this article explains what the current price might be indicating. The stock has returned 10.7% over the last 30 days, while the 1-year return is 3.8% and the 3-year return is 67.2%. These figures can influence how investors view both potential upside and risk. Recent coverage has highlighted MetLife's position as a major US insurance company. Investors have been focusing on how interest rate...
NYSE:UGI
NYSE:UGIGas Utilities

Is It Time To Reassess UGI (UGI) After Its Recent Share Price Weakness

If you are wondering whether UGI is attractively priced or just a value trap, starting with the current share price and valuation checks can help frame the picture. UGI closed at US$32.32, with recent returns showing a 10.4% decline over 7 days, 12.7% over 30 days, 14.1% year to date, and 3.6% over 1 year. This is set against a 31.7% gain over 3 years and an 11.3% decline over 5 years. These mixed return figures sit alongside ongoing investor attention on UGI as a regulated utility and...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape Starts Eagle Line As Licensing Revenue Story Begins

QuantumScape (NasdaqGS:QS) has started operations at its Eagle Line pilot-scale solid-state battery production facility. The company has recorded its first billings from ecosystem partners, initiating its licensing and royalty revenue stream. These developments represent a shift from pure development work to initial commercialization and monetization of its battery technology. QuantumScape focuses on solid-state lithium-metal batteries aimed at electric vehicles and related applications, a...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite FedRAMP Win Raises Questions On Undervalued Stock Weak Momentum

Cellebrite DI's Cellebrite Government Cloud platform has received FedRAMP High Authorization, the top federal cloud security standard. The U.S. Department of Justice acted as the sponsoring agency for this authorization. The approval covers handling of highly sensitive unclassified data for federal agencies. Cellebrite DI (NasdaqGS:CLBT) now has its Cellebrite Government Cloud cleared at the FedRAMP High level, placing it among a relatively small group of vendors that meet the federal...
NYSE:BRC
NYSE:BRCCommercial Services

Is It Too Late To Consider Brady (BRC) After Recent Share Price Weakness?

For investors wondering if Brady's current share price still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are really saying about the stock. Brady closed at US$79.53, with a 2.8% decline over the last 7 days and a 1.0% decline over 30 days, while still showing returns of 1.1% year to date and 9.9% over the last year. These price moves sit against a backdrop of ongoing investor interest in Commercial Services companies like Brady...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

Energy Recovery (ERII) Is Down 14.8% After Pulling 2026 Guidance And Announcing Leadership Changes

In the first quarter of 2026, Energy Recovery, Inc. reported sales of US$9.71 million, a wider net loss of US$12.25 million, a US$1.66 million goodwill impairment, and announced upcoming CEO retirement alongside the resignation of its CFO. The company also withdrew its 2026 financial guidance amid Middle East uncertainty, even as new product launches and desalination demand supported revenue growth. Next, we’ll examine how the withdrawal of 2026 guidance reshapes Energy Recovery’s investment...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Phathom (PHAT) Is Up 9.4% After Reaffirming 2026 Profitability Timeline And Narrowing Q1 Loss

In late April 2026, Phathom Pharmaceuticals reported that its first-quarter net loss narrowed to US$30.37 million from US$94.32 million a year earlier, while maintaining full-year 2026 net revenue guidance of US$320 million to US$345 million and expecting operating profitability, excluding stock-based compensation, to begin in the third quarter of 2026. The company also disclosed a change in how it classifies certain third-party costs starting January 1, 2026, which could make future margins...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND) Profit Swing To €10.2 EPS Tests Earnings Quality Concerns

Ascendis Pharma (NasdaqGS:ASND) has just posted its Q1 2026 numbers, with revenue of €246.6 million and basic EPS of €10.2, alongside trailing twelve month revenue of €865.8 million and basic EPS of €8.12. Over the past year, revenue has moved from €363.6 million in Q4 2024 to €865.8 million on a trailing basis, while basic EPS has shifted from a trailing loss of €6.53 to positive €8.12. This sets up a quarter where reported profitability and revenue scale give investors a clearer view of how...
NYSE:RITM
NYSE:RITMMortgage REITs

Is It Time To Revisit Rithm Capital (RITM) After Recent Share Price Weakness?

If you are wondering whether Rithm Capital at around US$9.79 is a bargain or a value trap, the starting point is understanding what the current price actually reflects. The stock has recent returns of 0.1% over 7 days, 3.1% over 30 days, a 10.8% decline year to date, a 4.7% decline over 1 year, 64.2% over 3 years and 59.1% over 5 years. This gives you a mixed picture of short term weakness against longer term gains. Recent headlines have focused on Rithm Capital's positioning within...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

Assessing TSS (TSSI) Valuation After Q1 2026 Earnings And New AI Leadership Hires

Why TSS (TSSI) is in focus after Q1 2026 earnings and leadership moves TSS (TSSI) is drawing attention after reporting Q1 2026 results that showed lower revenue and net income year over year, alongside new senior hires focused on AI infrastructure and enterprise technology. For the quarter ended March 31, 2026, TSS reported revenue of US$55.35 million compared with US$98.96 million a year earlier, with net income of US$2.28 million versus US$2.98 million in the prior period. Basic and diluted...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After Its 261% One-Year Surge?

Investors may be wondering if Indivior Pharmaceuticals at US$39.60 is still offering value after its strong run, or if most of the upside is already reflected in the price. The stock has returned 7.7% over the last week, 30.0% over the last month, 10.8% year to date and 260.7% over the last year. This naturally raises questions about how the risk reward trade off now looks. Recent news around Indivior Pharmaceuticals has focused on its position in the pharmaceuticals space and how the market...
NasdaqGS:CAR
NasdaqGS:CARTransportation

Avis Budget And Silver Airways Tie Up Adds Channel For CAR Investors

Avis Budget Group (NasdaqGS:CAR) has entered a new partnership with Silver Airways. Avis and Budget become Silver Airways’ preferred car rental providers for its travelers. The partnership is set to offer exclusive benefits to Silver Airways customers booking car rentals. Avis Budget Group, the parent company of the Avis and Budget car rental brands, is expanding its reach through this new airline partnership with Silver Airways. For readers, a key consideration is how closer integration...
NYSE:GFF
NYSE:GFFBuilding

Griffon Refocuses On North American Building Products And Shareholder Returns

Griffon (NYSE:GFF) is repositioning as a pure-play North American building products company. The company formed a joint venture for AMES North America and exited its UK and Australian operations. Management is pairing this focus with product development efforts and actions on dividends and share buybacks. For you as an investor, this refocus centers Griffon on a single region and core building products activities, rather than a mix of international operations. It follows an industry pattern...
NYSE:PR
NYSE:PROil and Gas

Is It Too Late To Consider Permian Resources (PR) After A 60% One-Year Surge?

Investors may be wondering whether Permian Resources, at around US$20 a share, still offers value or if most of the opportunity is already priced in. The stock has been volatile recently, with a 7.1% decline over the last week and a 6.1% decline over the last month. Even so, it still sits on a 39.4% return year to date and a 60.7% return over the last year. These moves come against a backdrop of ongoing attention on the company within the US energy sector, as investors weigh its position in...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Is It Time To Reassess PACCAR (PCAR) After Its Recent Share Price Pullback?

Wondering if PACCAR at around US$114 is offering fair value or if the market is missing something in the current price. The stock has eased back recently, with a 4.0% decline over the last 7 days and a 3.5% decline over the last 30 days, even though the 1 year return sits at 27.8% and the 5 year return at 117.8%. These moves come as PACCAR continues to attract attention in longer term performance discussions, where investors are weighing up its track record and future expectations. Recent...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Warrant Move And Defense Orders Reframe Dilution And Valuation Story

Amprius Technologies (NYSE:AMPX) announced a public warrant exchange with institutional holders aimed at reducing potential dilution and reshaping its capital structure. The company reported approximately US$500 million in new purchase orders from U.S. defense customers. Amprius also secured a US$21 million order from a leading Chinese electric mobility firm, pointing to growing commercial adoption across regions. For investors tracking battery suppliers, Amprius Technologies sits at the...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

Assessing Prairie Operating (PROP) Valuation After New US$4.2 Million Shelf Registration Filing

Prairie Operating (PROP) has filed a shelf registration to offer up to US$4.2 million in common stock, covering 4,000,000 shares. This move gives the company flexibility to raise capital. See our latest analysis for Prairie Operating. The shelf registration comes as Prairie Operating’s share price has declined 61.75% over the past 30 days and has a 47.74% year-to-date share price return. The 1-year total shareholder return is down 78.89%, pointing to fading momentum despite recent corporate...
NYSE:HRTG
NYSE:HRTGInsurance

Heritage Insurance Holdings (HRTG) Combined Ratio At 73.1% Challenges Bearish Earnings Decline Narrative

Heritage Insurance Holdings (HRTG) reported fourth quarter FY 2025 revenue of US$215.3 million with basic EPS of US$2.16, alongside trailing twelve month revenue of US$847.3 million and basic EPS of US$6.33. These figures sit against a trailing net profit margin of 23.1% versus 7.5% a year earlier and earnings growth of 217.8% over the past year. Over recent quarters, revenue has ranged from US$208.0 million to US$215.3 million, while quarterly basic EPS moved from US$0.99 in Q1 FY 2025 to...
NYSE:DNA
NYSE:DNALife Sciences

Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives

Ginkgo Bioworks Holdings (DNA) has wrapped up FY 2025 with fourth quarter revenue of about US$33.4 million and a basic EPS loss of US$1.41, alongside a net income loss of US$80.8 million. The company has seen trailing twelve month revenue move from US$227.0 million in Q4 2024 to US$170.2 million in Q4 2025. Over the same period, trailing EPS has shifted from a loss of US$10.54 to a loss of US$5.64, indicating that the business is still absorbing heavy costs even as losses on a per share basis...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly’s AI Security Growth Meets Falling Share Price And Valuation Gap

Fastly (NasdaqGS:FSLY) reported robust first quarter results with 20% year over year revenue growth. The company’s security business recorded 47% revenue growth, supported by new AI driven security products. Despite the operational performance and product launches, Fastly’s share price fell over 35% after the results as investor expectations exceeded the upgraded outlook. Fastly operates as an edge cloud and security platform, helping customers deliver and protect digital experiences closer...
NasdaqGM:MAAS
NasdaqGM:MAASInsurance

Is It Too Late To Consider Maase (MAAS) After A 64% Monthly Surge?

Wondering whether Maase at US$9.30 is priced for opportunity or already reflecting expectations? This article walks through what the current valuation suggests about the stock. Over the last month, the share price return of 64.0% and a year-to-date return of 59.7%, despite a 4.1% decline over the past week, indicate that the market's view on the stock has been shifting quickly. Recent coverage around Maase has focused on its positioning within the insurance sector and how investors are...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN (IREN) Q2 Loss Challenges Bullish Narratives Around Rapid AI Infrastructure Expansion

IREN (NasdaqGS:IREN) has reported a mixed Q2 2026, with revenue of US$184.7 million and a net loss of US$155.4 million, which translated to EPS of a US$0.52 loss, setting a very different tone to the strong Q1 print. Over the past six quarters, the company’s revenue has moved from US$52.8 million in Q1 2025 to US$240.3 million in Q1 2026 and then to US$184.7 million in Q2 2026. Over the same period, quarterly EPS has swung from a US$0.27 loss in Q1 2025 to US$1.42 in Q1 2026 and back to a...
NYSE:SILA
NYSE:SILAHealth Care REITs

Sila Realty Trust (SILA) Q4 FFO Near US$30 Million Tests Bullish Cash Flow Narrative

Sila Realty Trust (SILA) has closed out FY 2025 with fourth quarter revenue of US$50.7 million, basic EPS of US$0.09 and funds from operations of US$29.8 million, giving investors a clean snapshot of both top line activity and REIT specific cash generation. The company has seen quarterly revenue move from US$46.5 million in Q4 2024 to US$50.7 million in Q4 2025, while basic EPS shifted from US$0.20 to US$0.09 over the same stretch. This sets up an earnings season where the focus lands...